Newest first. 5.2k questions across 107 tags.
I have three numbers on my report that all claim to measure roughly the same risk and they do not agree about how I am doing. LDL-C 2.6 mmol/L, which is described in…
Details up front: CPC · Wuhan Wansheng Biotechnology. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
Concretely: aspartimide formation · oral semaglutide · Janoshik. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have…
This is the third vial from the same lot, so I can compare against two known-good ones. I have read the obvious sources and they disagree with each other, so I would…
Conditions: liraglutide · Nantong. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement than on…
What I am working with: sterile water for injection · ten days. I have read the obvious sources and they disagree with each other, so I would rather ask people who…
The specifics, since they change the answer: tirzepatide · three weeks · 30 °C. I am at the decision point and I would rather think it through than improvise. I would…
What I am working with: method section · Homopeptide. I am at the decision point and I would rather think it through than improvise. I would rather spend money on…
Stated plainly: tirzepatide · SURMOUNT-4. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear…
Stated plainly: 20 mg · 6.67 mg/mL. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and it…
Stated plainly: QSC · a GLP-1 receptor agonist. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I have read the primary source rather than the summary,…
Setup, so nobody has to ask: +3 · 4207.2 Da. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude…
What I have: a GLP-1 receptor agonist · six weeks · 37 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like…
The particulars: dizziness · orforglipron. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how…
Setup, so nobody has to ask: WWB · FGP · Japan. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
The specifics, since they change the answer: ApoB · dulaglutide. This is a planning question. I know what my options are; I do not know how to weigh them. What I want…
Details up front: a GLP-1 receptor agonist · six weeks · room temperature. This is a planning question. I know what my options are; I do not know how to weigh them.…
Conditions: TFC · Wuhan Wansheng Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works;…
What I am working with: QYB · semaglutide. An unexpected observation, and I would like a differential rather than reassurance. The conditions were within what I…
The particulars: 15 mg · 2 mL · phosphate-buffered diluent · orforglipron. I would like to define my thresholds before I have a result, for obvious reasons. I want a…
I have read the prescribing information and it addresses the adjacent case but not this one. I want a method I can write down and repeat, not a rule of thumb. I would…
I have had slow bowels since starting semaglutide and I have accepted that as the trade. Last week was different and it frightened me: four days with nothing, a hard…
For reference: 10 mg · three weeks · vomiting. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried…